BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12492113)

  • 1. Vasodilator-stimulated phosphoprotein (VASP) phosphorylation provides a biomarker for the action of exisulind and related agents that activate protein kinase G.
    Deguchi A; Soh JW; Li H; Pamukcu R; Thompson WJ; Weinstein IB
    Mol Cancer Ther; 2002 Aug; 1(10):803-9. PubMed ID: 12492113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
    Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
    Li Z; Ajdic J; Eigenthaler M; Du X
    Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation.
    Holt AW; Martin DN; Shaver PR; Adderley SP; Stone JD; Joshi CN; Francisco JT; Lust RM; Weidner DA; Shewchuk BM; Tulis DA
    Cell Signal; 2016 Sep; 28(9):1364-1379. PubMed ID: 27302407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein kinase G up-regulates expression of 15-lipoxygenase-1 in human colon cancer cells.
    Deguchi A; Xing SW; Shureiqi I; Yang P; Newman RA; Lippman SM; Feinmark SJ; Oehlen B; Weinstein IB
    Cancer Res; 2005 Sep; 65(18):8442-7. PubMed ID: 16166323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I; Del Mese P; Doronzo G; Mattiello L; Viretto M; Bosia A; Anfossi G; Trovati M
    Endocrinology; 2008 Apr; 149(4):1480-9. PubMed ID: 18079207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of the PKG substrate, vasodilator-stimulated phosphoprotein (VASP), in human cultured prostatic stromal cells.
    Cook AL; Haynes JM
    Nitric Oxide; 2007 Feb; 16(1):10-7. PubMed ID: 17049286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
    Soh JW; Kazi JU; Li H; Thompson WJ; Weinstein IB
    Mol Carcinog; 2008 Jul; 47(7):519-25. PubMed ID: 18163459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic AMP and cyclic GMP activate protein kinase G in cavernosal smooth muscle cells: old age is a negative factor.
    Lin CS; Liu X; Chow S; Lue TF
    BJU Int; 2002 Apr; 89(6):576-82. PubMed ID: 11942968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of VASP serine 157 phosphorylation in human neutrophils after stimulation by a chemoattractant.
    Eckert RE; Jones SL
    J Leukoc Biol; 2007 Nov; 82(5):1311-21. PubMed ID: 17684042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
    Yoon JT; Palazzo AF; Xiao D; Delohery TM; Warburton PE; Bruce JN; Thompson WJ; Sperl G; Whitehead C; Fetter J; Pamukcu R; Gundersen GG; Weinstein IB
    Mol Cancer Ther; 2002 Apr; 1(6):393-404. PubMed ID: 12477052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.
    Thompson WJ; Piazza GA; Li H; Liu L; Fetter J; Zhu B; Sperl G; Ahnen D; Pamukcu R
    Cancer Res; 2000 Jul; 60(13):3338-42. PubMed ID: 10910034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1.
    Soh JW; Mao Y; Kim MG; Pamukcu R; Li H; Piazza GA; Thompson WJ; Weinstein IB
    Clin Cancer Res; 2000 Oct; 6(10):4136-41. PubMed ID: 11051267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
    Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
    Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.
    Neo BH; Kandhi S; Wolin MS
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2295-304. PubMed ID: 21926339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells.
    Deguchi A; Thompson WJ; Weinstein IB
    Cancer Res; 2004 Jun; 64(11):3966-73. PubMed ID: 15173009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related decrease of protein kinase G activation in vascular smooth muscle cells.
    Lin CS; Liu X; Tu R; Chow S; Lue TF
    Biochem Biophys Res Commun; 2001 Sep; 287(1):244-8. PubMed ID: 11549281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
    Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
    Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Globular adiponectin increases cGMP formation in blood platelets independently of nitric oxide.
    Riba R; Patel B; Aburima A; Naseem KM
    J Thromb Haemost; 2008 Dec; 6(12):2121-31. PubMed ID: 18983522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
    Piazza GA; Thompson WJ; Pamukcu R; Alila HW; Whitehead CM; Liu L; Fetter JR; Gresh WE; Klein-Szanto AJ; Farnell DR; Eto I; Grubbs CJ
    Cancer Res; 2001 May; 61(10):3961-8. PubMed ID: 11358813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.